Most of the patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
mount a humoral immune response to the virus within a few weeks of infection, but the …

The study of protein subcellular distribution, their assembly into complexes and the set of
proteins with which they interact with is essential to our understanding of fundamental …

The SARS‐CoV‐2 virus Omicron variant has now supplanted wild‐type virus as the dominant
circulating strain globally. Three doses of mRNA COVID‐19 vaccine are recommended for …

Background: COVID-19 is more severe in transplant recipients. Variants of concern have
supplanted wild-type virus. In transplant recipients, data are limited on 2-dose or 3-dose …

Viral replication is dependent on interactions between viral polypeptides and host proteins.
Identifying virus-host protein interactions can thus uncover unique opportunities for …

BACKGROUND Limited information is available on the impact of immunosuppressants on
COVID-19 vaccination in patients with immune-mediated inflammatory diseases (IMID). …

Safe and effective vaccines are needed to end the COVID-19 pandemic. Here, we report the
preclinical development of a lipid nanoparticle–formulated SARS-CoV-2 mRNA vaccine, …

Prioritizing Ontario’s long-term care home (LTCH) residents for vaccination against severe
acute respiratory syndrome coronavirus 2 has drastically reduced their disease burden; …

Immunocompromised patients are predisposed to severe COVID-19. Here we compare
homotypic and heterotypic humoral and cellular immune responses to Omicron BA.1 in organ …

Proximity-dependent biotinylation strategies have emerged as powerful tools to characterize
the subcellular context of proteins in living cells. The popular BioID approach employs an …